The Advantages of MicroCal Auto-iTC200 for Secondary Screening in a Fragment Based Drug Discovery Campaign

This application note describes how MicroCal Auto‑iTC200 was used to identify and optimize potential lead compounds in an early drug discovery program for treatment of drug resistant tumors.